These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates...
Despite advancements in testing and treatment, over one million people became infected with HIV in 2022. This warrants a need for a revitalized focus on...
These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates...
The objectives of these present guidelines are: to provide updated evidence-informed guidance on treating infections caused by N. gonorrhoeae and C. trachomatis...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response...
As the HIV response moves to focusing on closing the remaining gaps in prevention, testing and treatment services, an evolution in the underlying routine...
In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may be offered as an additional HIV prevention option for people...
It is a priority for WHO to ensure that products are developed in a manner that supports optimal use globally, including in low- and middle-income...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical...